FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Clinical trials for FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD trials appear
Sign up with your email to follow new studies for FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Reishi mushroom shows promise for fatty liver in new trial
Disease control ENROLLING_BY_INVITATIONThis study tests whether Ganoderma lucidum (a type of mushroom) can improve antioxidant levels and liver health in 40 adults aged 35-49 with mild to moderate fatty liver disease. Participants will take the mushroom supplement, and researchers will measure changes in liver functio…
Matched conditions: FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Phase: NA • Sponsor: University of Agriculture, Peshawar • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
Total-body PET scanner reveals hidden metabolism clues in fatty liver disease
Knowledge-focused OngoingThis study uses advanced total-body PET scans to see how the body handles sugar and amino acids in healthy people and those with non-alcoholic fatty liver disease (NAFLD). About 36 adults aged 18-70 will receive a radioactive tracer by mouth or IV and have scans to track nutrient…
Matched conditions: FATTY LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE, NAFLD
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 17, 2026 07:08 UTC